SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,086.90 |
| Enterprise Value ($M) | 2,003.39 |
| Book Value ($M) | 350.92 |
| Book Value / Share | 4.27 |
| Price / Book | 5.95 |
| NCAV ($M) | 258.45 |
| NCAV / Share | 3.14 |
| Price / NCAV | 8.07 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.59 |
| Current Ratio | 3.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 381.10 |
| Assets | 473.57 |
| Liabilities | 122.65 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 163.36 |
| Operating Income | -210.96 |
| Net Income | -194.94 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -146.70 |
| Cash from Investing | 12.55 |
| Cash from Financing | 152.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 6.49 | 0.54 | |
| 13G/A | Braidwell Lp | 2.92 | -48.13 | |
| 13G/A | Redmile Group, LLC | 9.90 | 17.61 | |
| 13G/A | Vanguard Group Inc | 5.49 | -7.24 | |
| 13G/A | Flynn James E | 7.19 | 25.08 | |
| 13G/A | Brightstar Associates Llc | -0.21 | ||
| 13G/A | Goldman Sachs Group Inc | 2.50 | -47.67 | |
| 13G/A | BlackRock Inc. | 7.50 | 10.26 | |
| 13G/A | State Street Corp | 3.08 | -28.34 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 131,479 | 1,118,655 | 11.75 | |
| 149,734 | 1,940,709 | 7.72 | |
| 118,767 | 526,874 | 22.54 | |
| 144,102 | 871,798 | 16.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTMX – CytomX Therapeutics, Inc. | CYTK – Cytokinetics, Incorporated |
| DAWN – Day One Biopharmaceuticals, Inc. | DNLI – Denali Therapeutics Inc. |
| DSGN – Design Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io